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doi:10.1016/j.ejvsextra.2008.11.003Abstract Mycotic aneurysms of the common femoral artery are rare. They usually occur in
intravenous (IV) drug abusers using the femoral vessels for injection. Treatment options are
limited due to high graft-infection rates. We describe the first use of a bio-synthetic graft,
ilio-femoral bypass, for an infected aneurysm caused by an IV drug abuse.
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd.
Open access under CC BY-NC-ND license.Case Report
A 36-year-old male intravenous drug user (IVDU) presented
with a pulsatile left groin mass and pyrexia (Fig. 1). Distal
pulses were normal. Duplex scan revealed a 1.5-cm false
aneurysm of the common femoral artery above its bifur-
cation, confirmed by blood cultures growing Candida
species. Venous imaging showed extensive bilateral deep
vein thrombosis (DVT) and occluded long saphenous veins.
Antibiotic treatment, with intravenous (IV) Cefuroxime,
Metronidazole and Fluconazole (hospital guidelines), was
commenced immediately. The aneurysm expanded over the
next 4 days to a size of 2.7 cm on ultrasound, surrounded by
a collection. This initiated surgical intervention. At anaes-
thetic induction, the aneurysm occluded, causing acutejvs.2008.11.022.
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r Vascular Surgery. Published bylimb ischaemia. The external iliac and superficial femoral
arteries were ligated to de-vascularise the aneurysm. An
ilio-femoral bypass was performed using a bio-synthetic
(Omniflow II, Bio Nova) graft due to the extensive localFigure 1 Mycotic aneurysm pointing on to the skin.
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2 A. Chaudhry et al.sepsis and extensive DVT. Distal circulation returned to
normal.
Five days later, the patient began mobilising and was
discharged from the hospital. On first follow-up appoint-
ment at 6 weeks, the groin mass had reduced significantly in
size. The graft was pulsatile and foot pulses were all
palpable. Follow-up at 6 months with a duplex scan showed
a patent graft with good inflow and patent outflow vessels.
Discussion
Mycotic aneurysms are rare. The most common cause is IV
drug abuse. Other causes include septic embolisation,
extension from local infection or trauma. The prevalence
rate is 0.03% in IVDUs.1 Complications include systemic
sepsis, local extension of infection, vessel rupture and
arterial occlusion leading to limb ischaemia.
Treatment consists of arterial ligation with or without
re-vascularisation. Long-term follow-up after ligation alone
demonstrates a high risk of chronic limb ischaemia2 with
ABIs ranging from 0.41 to 0.58.
Autologous extra-anatomical bypass is challenging in
intravenous drug abusers with poor availability of suitable
vein. Extra-anatomical bypass with polytetrafluoroethylene
(PTFE) or Dacron is usually avoided in favour of ligation due
to the high rates of infection.3 Endovascular stent-grafting
of infected aneurysms has also been described, but the
longer-term durability of this approach is unclear. Strict
compliance with close monitoring of the stent-graft is
essential,4 but rarely possible in such patients.
The procedure we describe here uses a bio-synthetic
graft. The Omniflow graft is a composite of an endoskeleton
polyester mesh and ovine/sheep collagen that is designed to
provide the dual benefits of durability from synthetic
material and haemocompatible flow from the use of bio-
logical material (Fig. 2). Studies in renal access have shownFigure 2 Omniflow graft in situ after anastamosis.infection rates from 0% to 3.4%,5 as compared to 3% and 13%
with PTFE and Dacron, respectively, when used extra-
anatomically.
Bio-synthetic material is also an attractive long-term
option due to its bio-compatibility allowing the integration
of the graft into host tissues as well as true micro-vascu-
larisation of the graft vessel wall.
The use of bio-synthetic prostheses for arterial bypass
surgery and AV fistulas in haemodialysis patients has been
well described. We believe that this is the first described
case of a bio-synthetic graft used for a patient with
a mycotic aneurysm.
Conclusions
Current surgical options for the treatment of mycotic
aneurysms consist of arterial ligation and later
re-vascularisation, if necessary, using extra-anatomical
bypass with autologous or prosthetic grafts.
In this article, we have described the combined
approach of vessel ligation in continuity and the use of
a bio-synthetic graft to restore circulation. This may be
a better alternative to current surgical therapy. Our
method avoids the isolated ligation of vessels, which often
leads to post-procedure limb ischaemia. There is less need
for secondary re-vascularisation thus reducing the need for
multiple surgical interventions.
Further experience and long-term follow-up is needed to
establish this as a viable option for the surgical treatment
of mycotic aneurysms.Conflict of Interest
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